Application of pseudostrychnine to inhibiting human colon cancer cells

A technology of colon cancer cells and strychnine, which is applied in the field of chemical medicine, can solve the problems of unreported application of pseudo strychnine, and achieve the effect of inhibiting proliferation and promoting apoptosis

Inactive Publication Date: 2019-06-21
山西中医学院中西医结合医院
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology helps preventing colorectal carcinoma by blocking certain proteins that help it grow or kill them effectively. It also suggests treatments like chemotherapy with this compound.

Problems solved by technology

This patented technical problem addressed in this patents relates to finding ways to reduce or prevent colorectal carcinoma (CRC) growth without causing harmful side effects such as negative reactions towards certain drugs like antibiotics.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pseudostrychnine to inhibiting human colon cancer cells
  • Application of pseudostrychnine to inhibiting human colon cancer cells
  • Application of pseudostrychnine to inhibiting human colon cancer cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Anti-proliferation experiment of pseudostychnine on HT-29 cells

[0019] 1. Cell culture

[0020] Take the HT-29 cells out of the liquid nitrogen, quickly put them into a 37°C water bath, shake the cryopreservation tube gently to dissolve the cryopreservation solution, transfer the cells to a centrifuge tube containing 5mL medium after dissolution, and collect the cells by centrifugation. Room temperature 1000r·min -1 Discard the supernatant after centrifugation for 5 minutes; suspend the cells with MC5A complete medium containing 10% fetal bovine serum, inoculate them into a petri dish, and gently pipette to mix well, at 37°C, 5% CO 2 cultured under saturated humidity conditions. Cells were passaged when the cell density reached 80%.

[0021] 2. MTT test

[0022] Take HT-29 cells in logarithmic growth phase and in good growth state, adjust the cell density to 3×10 with MC5A complete medium containing 10% fetal bovine serum 4 cells / mL, after inserting int

Embodiment 2

[0031] Embodiment 2: Effect experiment of pseudostychnine on the cell cycle of HT-29 cells

[0032] Take the HT-29 cells that are in the logarithmic growth phase and in a good growth state cultivated in Example 1, and use 2.5×10 5 Cells were seeded in a 6-well plate for cell culture at 37°C, 5% CO 2 Incubate overnight in the incubator. Set the pseudo-stychnine concentration to 0 μmol L -1 The concentration of blank control group and pseudo strychnine was 250 μmol L -1 The experimental group, 37 ℃, 5% CO 2 After culturing in the incubator for 48 hours, the cells were collected. Digest cells with 0.25% trypsin without EDTA, collect cells after termination of digestion, 1000r·min -1 Centrifuge for 5 minutes, remove the supernatant, resuspend and wash with PBS buffer twice, and then centrifuge again to remove the supernatant. Take 100 μL of PBS to resuspend the cells, slowly add 700 μL of pre-cooled 80% ethanol to make the final concentration of ethanol to 70%, and fix at 4°C f

Embodiment 3

[0034] Example 3: Effect of different concentrations of pseudostychnine on the apoptosis of HT-29 cells

[0035] 1. Cell culture

[0036] HT-29 cells were cultured in complete medium containing 10% fetal bovine serum, MC5A+10% FBS+1% penicillin-streptomycin mixed solution, placed at 37°C, 5% CO 2 Incubate and cultivate under saturated humidity conditions in a constant temperature incubator.

[0037] 2. Grouping and administration

[0038] A blank control group without pseudostychnine and three experimental groups with different concentrations of pseudostychnine were set up. The HT-29 cells in logarithmic phase growth were randomly divided into 4 parts, 3 of which were added with pseudo-stychnine at concentrations of 125 μmol / L, 250 μmol / L, and 500 μmol / L respectively, as the experimental group, and the other group was added with the experimental group. The same dose of culture medium in the group was used as the blank control group, and each group had three replicate wel

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of chemical medicine, particularly relates to application of pseudostrychnine to inhibiting human colon cancer cells and aims at providing new application of the pseudostrychnine to inhibiting the human colon cancer cells. The human colon cancer cells are HT-29 cells; the pseudostrychnine can inhibit propagation of the HT-29 cells and promote apoptosis of the HT-29 cells, and the apoptosis rate is in positive correlation with the concentration of the pseudostrychnine; the applied concentration of the pseudostrychnine is 125-1000 mu M. The application of the pseudostrychnine to the inhibiting human colon cancer cells provides a new way for treating human colon cancer and has an important development and application prospect in antitumor drugs.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 山西中医学院中西医结合医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products